In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

We believe Perrigo is in fine financial health. At the end of 2024, the company had roughly $560 million in cash and equivalents with about $3.3 billion in long-term debt. Its balance sheet was in a ...